Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2022-08-03 00:00:00 ET · period of report 2022-08-01 · accession 0001765581-22-000073 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-03 | 2022-08-01 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | S - Sale+OE | $154.31 | -7,301 | 354.3K | -2% | -$1.13M |
| DM | 2022-08-03 | 2022-08-01 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | M - OptEx | $46.92 | +9,700 | 361.6K | +3% | +$455.1K |
| DM | 2022-08-03 | 2022-08-01 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | M - OptEx | $0.00 | -9,700 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-08-01 | S | D | 2,600 | $153.48 | 359,012 | D | — | — | (F2) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $153.01 to $153.935. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 2 | Common | Ordinary Shares | 2022-08-01 | S | D | 2,601 | $154.50 | 356,411 | D | — | — | (F3) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $154.01 to $154.95. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 3 | Common | Ordinary Shares | 2022-08-01 | S | D | 1,100 | $155.27 | 355,311 | D | — | — | (F4) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $155.015 to $155.66. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 4 | Common | Ordinary Shares | 2022-08-01 | S | D | 1,000 | $154.94 | 354,311 | D | — | — | |
| 5 | Common | Ordinary Shares | 2022-08-01 | M | A | 9,632 | $46.83 | 361,544 | D | — | — | |
| 6 | Common | Ordinary Shares | 2022-08-01 | M | A | 68 | $59.13 | 361,612 | D | — | — | |
| 7 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-08-01 | M | D | 68 | $0.00 | 72,605 | D | $59.13 · — to 2023-03-04 | 68 Ordinary Shares | (F7) This non-qualified stock option is part of an option granted on March 5, 2013. The ordinary shares subject to this option vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of March 5, 2017. |
| 8 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-08-01 | M | D | 9,632 | $0.00 | 0 | D | $46.83 · — to 2022-08-08 | 9,632 Ordinary Shares | (F6) This Non-qualified stock option is part of an option granted on August 9, 2012. The ordinary shares subject to this option vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of August 9, 2016. |